China Foods Holdings Ltd. revenue by segment CFOO

China Foods Holdings Ltd. splits its revenue into 4 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Salesof Healthcare at $258,802, 79% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line
FY 2026
Jun 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Sep 30, 2019
FY 2018
Sep 30, 2018
FY 2017
Sep 30, 2017
FY 2016
Sep 30, 2016
Revenue
0
0
0
0
0
0
1
—
0
0
0
Salesof Healthcare
—
0
+144.1%
share 78.9%
0
+3070.6%
share 45.4%
0
-91.6%
share 2.1%
0
+24.2%
share 11.2%
0
-93.4%
share 8.8%
0
share 47.5%
—
—
—
—
Consultancy Service Fee Income
—
0
+249.9%
share 20.8%
0
+22.3%
share 8.4%
0
-88.7%
share 10.1%
0
-35.0%
share 39.8%
0
-1.9%
share 60.1%
0
share 21.8%
—
—
—
—
Saleof Healthcare Products
—
—
—
—
—
0
-92.9%
share 11.1%
1
share 55.7%
—
—
—
—
Sale Of Wine Products
—
0
-99.3%
share 0.2%
0
-22.5%
share 46.2%
0
-19.8%
share 87.8%
0
+54.3%
share 49.0%
0
-63.9%
share 31.1%
0
share 30.7%
—
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
CFOO (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Wanchai, Hong Kong
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1310630
Former names
Trafalgar Resources, Inc. (until Feb 20, 2019)

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.